@article{article, title = {{Cost effectiveness of ranibizumab vs aflibercept vs bevacizumab for the treatment of macular oedema due to central retinal vein occlusion: the LEAVO study}}, publisher = {{Springer}}, url = {{http://eprints.whiterose.ac.uk/173442/ }}, year = {{2021}}, month = {{4}}, author = {{Pennington R and Alshreef A and Flight L and Metry A and Poku E and Hykin P and Sivaprasad S and Prevost AT and Vasconcelos JC and Murphy C and Kelly J et al}}, doi = {{10.1007/s40273-021-01026-5}}, journal = {{PharmacoEconomics}}, note = {{Accessed on 2025/05/09}}}